Investors / PL Neuro
PL Neuro
Investor
PL Neuro is a project by Protocol Labs that makes strategic investments and conducts scientific research in neurotechnology and NeuroAI. It defines research milestones, funds research, and routes talent and capital toward problems such as neural augmentation, biologically-inspired intelligence, and whole organism emulation.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsneurotechnologyneuroaibrain-computer interfacesneuroscienceartificial intelligenceresearch
Your fit with PL Neuro
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsPL Neuro lists 11 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (59%), AI & Machine Learning (35%) and Education (6%). 83% of its companies are based in United States. It invests most often alongside Forepont Capital Partners, Perridon Ventures and 15th Rock.
No funding round on record names PL Neuro yet, so the figures come from its portfolio page.
Round figures show recent activity, not PL Neuro's whole history. Rounds on record name 0 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 88th | 59% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 59% | 15% |
| AI & Machine Learning | 35% | 18% |
| Education | 6% | 7% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Forepont Capital Partners
Compare PL Neuro head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Convergent Research launches non-profit startups to build foundational capabilities for technological progress by identifying and addressing scientific bottlenecks | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| E11 Bio develops technologies for brain circuit mapping and reconstruction | Healthcare & Biotech | Portfolio page | ||
| Eon Systems emulates the human brain to enable humans to flourish in a world with superintelligence | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Foresight Institute is a research organization that supports pioneering scientists and innovators advancing technologies that benefit the future of life. | AI & Machine LearningHealthcare & Biotech | Portfolio page | ||
| Hemispheric is building a foundational AI platform that translates non-invasive brain activity into actionable understanding | Healthcare & Biotech | Portfolio page | ||
| The company builds neurotechnology to help monitor and regulate brain health and performance | Healthcare & Biotech | Portfolio page | ||
| Netholabs builds recording systems, cross-species datasets, and foundation models of living organisms | AI & Machine LearningHealthcare & Biotech | Portfolio page | ||
| Neuromatch provides educational courses and career-development programs in computational science, AI, and neuroscience | EducationAI & Machine Learning | Portfolio page | ||
| Paradromics develops brain-computer interface platforms to restore lost capabilities and advance human possibility through technology. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Precision Neuroscience develops brain-computer interfaces to help people with paralysis operate digital devices using only their thoughts | Healthcare & Biotech | Portfolio page | ||
| Synchron builds implantable Brain-Computer Interfaces to protect what makes you human. | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- plneuro.xyz
- Last read
- 8 Nov 2026
- Watching since
- 8 Nov 2026
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get PL Neuro's profile as data
Pull PL Neuro's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/plneuro.xyz
# also
GET /v1/firms/plneuro.xyz/portfolio
GET /v1/firms/plneuro.xyz/coinvestors
GET /v1/firms/plneuro.xyz/news